US Stock MarketDetailed Quotes

ARWR Arrowhead Pharmaceuticals

Watchlist
  • 18.625
  • +0.015+0.08%
Trading Dec 31 15:38 ET
2.32BMarket Cap-3.73P/E (TTM)

Arrowhead Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Arrowhead Pharmaceuticals Q4 2024 Earnings Date

Currency：USDNov 26, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
EPS
-0.87
-1.37
-0.50
Miss Est.
+14.59%
-34.31%
-57.27%
Net Income
--
-173.34M
--
-56.14%
Analyst Rating
Buy

Dec 25, 2024

Arrowhead Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 11 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 71.909M--
--2025/Q1-- / 62.773M--
Nov 26, 20242024/Q40.000 / 58.913M--
Aug 8, 20242024/Q30.000 / 37.142M--
May 9, 20242024/Q20.000 / 56.830M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 71.909M--
--2025/Q1-- / 62.773M--
Nov 26, 20242024/Q40.000 / 58.913M--
Aug 8, 20242024/Q30.000 / 37.142M--
May 9, 20242024/Q20.000 / 56.830M--

Unlock Free Earnings Estimates

Arrowhead Pharmaceuticals Earnings Reports

  • Arrowhead Pharmaceuticals | 10-K: FY2024 Annual Report

    Nov 27, 2024 11:32

  • Arrowhead Pharmaceuticals | 8-K: Arrowhead Pharmaceuticals Reports Fiscal 2024 Third Quarter Results

    Aug 9, 2024 04:53

  • Arrowhead Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

    Aug 9, 2024 04:50

  • Arrowhead Pharmaceuticals | 8-K: Arrowhead Pharmaceuticals Reports Fiscal 2024 Second Quarter Results

    May 10, 2024 05:10

    • Read more

    Analysis

    Analyst Rating

    Updated: Dec 25, 2024

    Buy

    • Buy

      54.55%

    • Hold

      45.46%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data